Insulin-like growth factor II induces apoptosis in osteoblasts

Bone

Volumn 35, Issue 3, 2004, Pages 621-628

  Gronowicz, Gloria A ^a   McCarthy, Mary Beth ^a   Zhang, Hai ^a   Zhang, Wenjian ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Apoptosis; Bax; Bcl 2; Bone; Insulin growth factor II (IGF II); Osteoblasts

Indexed keywords

ACRIDINE ORANGE; ETHIDIUM BROMIDE; PROTEIN BCL 2; SOMATOMEDIN B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC LINKAGE; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; NONHUMAN; OSTEOBLAST; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL COUNT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, TRANSGENIC; OSTEOBLASTS;

EID: 4344691648     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.05.005     Document Type: Article

References (29)

1. Rosen C. Serum insulin-like growth factor and insulin-like growth factor-binding proteins: clinical implications. Clin. Chem. 45((8B):1999;1384- 1390
2. MacDonald R., Pfeffer S., Coussens L., Tepper M., Brockleband C., Mole J., et al. A single receptor binds insulin-like growth factor II and mannose-6 phosphate. Science. 239:1998;1134-1137
3. 125I insulin-like growth factor Ii degradation by modulating the Igf-II receptor recycling process. J. Biol. Chem. 260:1985;9435-9442
4. Jones J., Clemmons D. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;33-34
5. Conover C. The role of insulin-like growth factors and binding proteins in bone biology. Bilezekian J.K., Raisz L.G., Rodan G.A. Principles of bone biology. 1996;607-618 Academic Press, Inc., New York
6. Powell-Braxton L., Hollongshead P., Warburton C., Dowd M., Pitts-Meek S., Dalton D., et al. Igf-I is required for normal embryonic growth in mice. Genes Dev. 7:1993;2609-2617
7. Van Wyck J., Smith E. Insulin-like growth factors and skeletal growth: possibilities for therapeutic interventions. J. Clin. Endocrinol. Metab. 84:1999;4349-4354
8. Liu J.-H., Baker J., Perkins A., Robertson E., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor (Igf-1) and Type I IGF receptor (Igf1r). Cell. 75:1993;59-72
9. Baker J., Liu J.-P., Robertson E., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:1993;73-82
10. Gohel A., McCarthy M., Gronowicz G. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology. 140:1999;5339-5347
11. Gronowicz G., McCarthy M., Zhang H. IGF-II induces apoptosis and IGF-I prevents glucocorticoid-induced apoptosis in primary human and rat osteoblasts. J. Bone Miner. Res. 16:2001;S358
12. Stewart C., Rotwein P. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J. Biol. Chem. 271:1996;11330-11338
13. Nicholas R., Stevens S., Wing M., Compston D. Microglia-derived IGF-2 prevents TNFalpha induced death of mature oligodendrocytes in vitro. J. Neuroimmunol. 124:2002;36-44
14. Stewart C., Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76:1996;1005-1026
15. Korsmeyer S. Regulators of cell death. Trends. Genet. 11:1995;101-105
16. Adams J., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326
17. Beresford J., Gallagher J., Poster J., Russell R. Production of osteocalcin by human bone cells in vitro. Effect of 1,25 (OH)2D3, 24, 25(OH)2D3, parathyroid hormone and glucocorticoids. Metab. Bone Dis. Relat. Res. 5:1984;229-234
18. Cleary M.L., Smith S.D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:1986;19-28
19. Pavlin D., Lichtler A.C., Bedalov A., Kream B.E., Harrison J.R., Thomas H.F., et al. Differential utilization of regulatory domains within the alpha(I)collagen promoter in osseous and fibroblastic cells. J. Cell Biol. 116:1992;227-236
20. Lu Q., Poulsom R., Wong L., Hanby A. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol. 169:1993;431-437
21. Lynch M.P., Capparelli C., Stein J.L., Lian J.B. Apoptosis during bone-like development in vitro. J. Cell. Biochem. 68:1998;31-49
22. Efstratiadis A. Genetics of mouse growth. Int. J. Dev. Biol. 42:1998;955-976
23. Ludwig T., Eggenschwiler L., Fisher P., D'Ercole A., Davenport M., Efstratiadis A. Mouse mutants lacking the type 2 receptor (IGF2R) are rescued from perinatal lethality in Igf2 and IGf1r null backgrounds. Dev. Biol. 177:1996;517-535
24. Filson A., Louvi A., Efstratiadis A., Robertson E. Rescue of the T-associated maternal effect in mice carrying null mutations in IGF-2 and IGF-2r, two reciprocally imprinted genes. Development. 118:1993;731-736
25. Kang J., Li Y., Leaf A. Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc. Natl. Acad. Sci. 94:1997;13671-13676
26. Haydon R., Zhou L., Feng T., Breyer B., Cheng H., Jiang W., et al. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin. Cancer Res. 8:2002;1288-1294
27. Gordeladze K., Dreven C., Syversen U., Reseland J. Leptin stimulates human osteoblastic cell proliferation, de novo, collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J. Cell. Biochem. 85:2002;825-836
28. Souza R., Wang S., Thakar M., Smolinski K., Yin J., Zou T.-T., et al. Expression of the wild-type insulin growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene. 18:1999;4063-4068
29. Vincent A., Feldman E. Control of cell survival by IGF signaling pathways. Growth Horm. IGF Res. 12:2002;193-197